Logotype for Best Agrolife Limited

Best Agrolife (539660) Q1 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Best Agrolife Limited

Q1 24/25 earnings summary

8 Jul, 2026

Executive summary

  • Q1 FY25 revenue declined to INR 519 crore from INR 612 crore in Q1 FY24, driven by a strategic shift to branded business, lower institutional sales, and delayed monsoon impacting sales timing.

  • Branded sales rose to 63% of revenue from 55% last year, reflecting a focus on higher-margin patented products and innovation.

  • Several new patented products were launched, including Orisulam, Nemagen, Warden Extra, and Defender, with a new patent secured for a synergistic pesticidal composition.

  • International expansion included opening a subsidiary in Shanghai, China, and pursuing product registrations in multiple countries.

  • Board approved unaudited financial results for Q1 FY25, reviewed by the Audit Committee and Board on 12 August 2024.

Financial highlights

  • Q1 FY25 consolidated revenue was ₹5,192.60 million, down from ₹6,122.32 million in Q1 FY24; EBITDA dropped to ₹55 crore from ₹130 crore, with margin falling to 11% from 21% year-over-year.

  • Q1 FY25 consolidated net profit was ₹212.75 million, compared to ₹905.04 million in Q1 FY24; PAT margin at 4% versus 15% a year ago.

  • Branded business volumes increased by 21%, but price erosion of 19% led to flat branded revenue growth (1%-2% increase).

  • Trading revenue accounted for 20% of total business, down from 30% previously, and is expected to decrease further.

  • Sequentially, Q1 FY25 revenue and profitability were significantly higher than Q4 FY24, which saw only ₹135 crore in revenue and negative EBITDA.

Outlook and guidance

  • FY25 revenue growth is guided at 15%-20%, with EBITDA margin expected in the 15%-17% range.

  • Q2 and subsequent quarters are expected to show improved margins and higher contributions from new patented products as inventory issues resolve and monsoon conditions remain favorable.

  • Management expects significant inventory liquidation by September and December, improving the balance sheet.

  • Focus on launching new, higher-margin products, ramping up branded business, and improving cash flow and working capital cycle.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more